Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioactive stents.

T A Fischell1

  • 1Heart Institute, Borgess Medical Center, Kalamazoo, MI, USA. taf1@net-link.net

Seminars in Interventional Cardiology : SIIC
|April 23, 1999
PubMed
Summary
This summary is machine-generated.

Radioactive stents, using low doses of isotopes like 32P, show promise in preventing in-stent restenosis after coronary artery disease treatment. Early trials indicate excellent safety and procedural success, paving the way for larger studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracoronary brachytherapy in the porcine model: a different animal.

Circulation·2001
Same author

Failure of a novel balloon-expandable gamma-emitting ((103)Pd) stent to prevent edge effects.

Circulation·2001
Same author

Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: a quantitative coronary analysis of Duet and NIR stent implantation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis.

Cardiovascular radiation medicine·2000
Same author

Visible stents: all that glitters...is it gold?

The Journal of invasive cardiology·2000
Same author

Ultrasound thrombolysis for the treatment of thrombotic occlusion of degenerated saphenous vein grafts.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2000
Same journal

Atherectomy plus stenting: what do we gain?

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of directional coronary atherectomy for the treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

The place of rotablator for treatment of in-stent restenosis.

Seminars in interventional cardiology : SIIC·2001
Same journal

Directional coronary atherectomy: optimal atherectomy trials and new combined strategies with coronary stents.

Seminars in interventional cardiology : SIIC·2001
Same journal

Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.

Seminars in interventional cardiology : SIIC·2001
Same journal

Morphological analysis of atherosclerotic plaque retrieved by coronary atherectomy.

Seminars in interventional cardiology : SIIC·2001
See all related articles

Area of Science:

  • Interventional Cardiology
  • Radiation Oncology
  • Biomedical Engineering

Background:

  • Intracoronary stenting is a key treatment for obstructive coronary artery disease.
  • In-stent restenosis remains a significant complication, especially in small vessels and long lesions.
  • The proliferative process following stenting is the primary cause of restenosis.

Purpose of the Study:

  • To review the concept of using radioactive stents to inhibit in-stent restenosis.
  • To summarize initial clinical safety trial results of radioactive stents.
  • To assess the potential therapeutic effect of radioactive stents.

Main Methods:

  • Review of studies on radioactive stents in animal models.
  • Summary of Phase-1 safety trials involving radioactive stents.

Related Experiment Videos

  • Analysis of procedural and short-term clinical outcomes.

    • Main Results:

    • Radioactive stents demonstrated efficacy in animal models of restenosis.
    • Over 200 implants of 32P Palmaz-Schatz and BX radioactive stents showed excellent procedural success.
    • Excellent 30-day event-free survival was observed in early clinical trials.

    Conclusions:

    • Radioactive stents represent a promising approach to reduce in-stent restenosis.
    • Initial clinical data suggest favorable safety and efficacy.
    • Further dose-finding and large-scale randomized trials are planned to confirm therapeutic benefit.